SCHEMBL26287997

SCHEMBL26287997

C[C@]1(O)[C@@H](CO)O[C@@H](N2C=CC(=O)NC2O)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19537499 0.77 ADORA2A (0.39) —
SCHEMBL23225546 0.77 ADORA2A (0.39) —
SCHEMBL23906506 0.77 ALDH1A1 (0.41) —
SCHEMBL21283173 0.74 CDA (0.47) —
SCHEMBL26798971 0.74 CDA (0.39) —
SCHEMBL24831415 0.74 — —
SCHEMBL19993700 0.73 — —
SCHEMBL23353386 0.71 TK2 (0.37) —
SCHEMBL14510444 0.71 TK2 (0.37) —
SCHEMBL21283066 0.71 TK2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023178133-A9 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-10-26 — — WO disclosed
WO-2023178133-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-09-21 — — WO disclosed
Send feedback